Neogen Corporation, including its affiliated companies, is a global leader in creating, manufacturing, and distributing a wide range of products crucial for maintaining food quality and animal health. The enterprise is structured into two primary divisions: Food Safety and Animal Safety. The Food Safety segment delivers advanced diagnostic test kits and associated solutions to identify detrimental or unintended contaminants in food and animal feed. This extensive detection capability covers threats such as foodborne pathogens, spoilage-causing organisms, naturally occurring toxins, food allergens, genetically modified ingredients, ruminant by-products, specific meat identification, residual drugs and pesticides, and overall sanitation issues. A key product is the AccuPoint Advanced rapid sanitation test, which quickly spots adenosine triphosphate (ATP), indicating the presence of living cells, to verify cleanliness. Customers for this segment are diverse, encompassing producers and processors of food and feed, grain operations, manufacturers of processed foods like cookies, crackers, candy, and ice cream, as well as those handling meat, poultry, seafood, fruits, vegetables, and dairy. It also serves laboratories and producers of pharmaceuticals, cosmetics, and veterinary vaccines. The Animal Safety division provides a comprehensive portfolio for the animal health market. Offerings include veterinary instruments, pharmaceuticals, vaccines, topical medications, parasiticides, diagnostic products, rodenticides, cleaning agents, disinfectants, insecticides, and genomics testing services. This segment also supplies specialized products for researchers investigating biologically active substances. Its immunoassay test kits are vital for detecting illicit and therapeutic drugs in farm and racing animals, identifying drug residues in meat and meat products, and assisting in human forensic toxicology drug screenings. Moreover, products from this division are instrumental in upholding hygienic conditions and minimizing the risks posed by bacteria, fungi, and viruses. Neogen Corporation was established in 1981 and is headquartered in Lansing, Michigan.
前日終値
$11.85
+$0.14 · +1.20%
日中の時刻はETです。市場データは遅延する場合があります。
Neogen Corporation, including its affiliated companies, is a global leader in creating, manufacturing, and distributing a wide range of products crucial for maintaining food quality and animal health. The enterprise is structured into two primary divisions: Food Safety and Animal Safety. The Food Safety segment delivers advanced diagnostic test kits and associated solutions to identify detrimental or unintended contaminants in food and animal feed. This extensive detection capability covers threats such as foodborne pathogens, spoilage-causing organisms, naturally occurring toxins, food allergens, genetically modified ingredients, ruminant by-products, specific meat identification, residual drugs and pesticides, and overall sanitation issues. A key product is the AccuPoint Advanced rapid sanitation test, which quickly spots adenosine triphosphate (ATP), indicating the presence of living cells, to verify cleanliness. Customers for this segment are diverse, encompassing producers and processors of food and feed, grain operations, manufacturers of processed foods like cookies, crackers, candy, and ice cream, as well as those handling meat, poultry, seafood, fruits, vegetables, and dairy. It also serves laboratories and producers of pharmaceuticals, cosmetics, and veterinary vaccines. The Animal Safety division provides a comprehensive portfolio for the animal health market. Offerings include veterinary instruments, pharmaceuticals, vaccines, topical medications, parasiticides, diagnostic products, rodenticides, cleaning agents, disinfectants, insecticides, and genomics testing services. This segment also supplies specialized products for researchers investigating biologically active substances. Its immunoassay test kits are vital for detecting illicit and therapeutic drugs in farm and racing animals, identifying drug residues in meat and meat products, and assisting in human forensic toxicology drug screenings. Moreover, products from this division are instrumental in upholding hygienic conditions and minimizing the risks posed by bacteria, fungi, and viruses. Neogen Corporation was established in 1981 and is headquartered in Lansing, Michigan.
日中レンジ
現在 $11.85
52週レンジ
現在 $11.85
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
中立
バリュエーション
47
適正価値
センチメント
53
まちまち
リスク
48
やや高いリスク
モメンタム
57
中立
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
Neogen Corporation, including its affiliated companies, is a global leader in creating, manufacturing, and distributing a wide range of products crucial for maintaining food quality and animal health. The enterprise is structured into two primary divisions: Food Safety and Animal Safety. The Food Safety segment delivers advanced diagnostic test kits and associated solutions to identify detrimental or unintended contaminants in food and animal feed. This extensive detection capability covers threats such as foodborne pathogens, spoilage-causing organisms, naturally occurring toxins, food allergens, genetically modified ingredients, ruminant by-products, specific meat identification, residual drugs and pesticides, and overall sanitation issues. A key product is the AccuPoint Advanced rapid sanitation test, which quickly spots adenosine triphosphate (ATP), indicating the presence of living cells, to verify cleanliness. Customers for this segment are diverse, encompassing producers and processors of food and feed, grain operations, manufacturers of processed foods like cookies, crackers, candy, and ice cream, as well as those handling meat, poultry, seafood, fruits, vegetables, and dairy. It also serves laboratories and producers of pharmaceuticals, cosmetics, and veterinary vaccines. The Animal Safety division provides a comprehensive portfolio for the animal health market. Offerings include veterinary instruments, pharmaceuticals, vaccines, topical medications, parasiticides, diagnostic products, rodenticides, cleaning agents, disinfectants, insecticides, and genomics testing services. This segment also supplies specialized products for researchers investigating biologically active substances. Its immunoassay test kits are vital for detecting illicit and therapeutic drugs in farm and racing animals, identifying drug residues in meat and meat products, and assisting in human forensic toxicology drug screenings. Moreover, products from this division are instrumental in upholding hygienic conditions and minimizing the risks posed by bacteria, fungi, and viruses. Neogen Corporation was established in 1981 and is headquartered in Lansing, Michigan.
日中レンジ
現在 $11.85
52週レンジ
現在 $11.85
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標(USD) | 2026年度 | 2025年度 | 2024年度 | 2023年度 | 2022年度 |
|---|---|---|---|---|---|
| 売上高 | 8.7億 USD | 8.95億 USD | 9.24億 USD | 8.22億 USD | 5.27億 USD |
| 売上原価 | 4.62億 USD | 4.73億 USD | 4.62億 USD | 4.16億 USD | 2.84億 USD |
| 粗利益 | 4.09億 USD | 4.21億 USD | 4.63億 USD | 4.06億 USD | 2.43億 USD |
| 研究開発 | 1840万 USD | 2108.7万 USD | 2247.6万 USD | 2603.9万 USD | 1704.9万 USD |
| 販売・一般管理 | 4.12億 USD | 4.02億 USD | 3.83億 USD | 3.42億 USD | 1.67億 USD |
| 営業費用 | 4.3億 USD | 4.12億 USD | 3.85億 USD | 3.68億 USD | 1.84億 USD |
| 受取利息 | — | 311万 USD | 636.2万 USD | 316.6万 USD | 133.9万 USD |
| 支払利息 | 5760万 USD | 7162.2万 USD | 7339.4万 USD | 5596.1万 USD | 7.2万 USD |
| 減価償却費と償却費 | 1.16億 USD | 1.26億 USD | 1.21億 USD | 9047.4万 USD | 2413.2万 USD |
| 営業利益 | −2160万 USD | 942万 USD | 7742.6万 USD | 3751.5万 USD | 5861.8万 USD |
| 純利益 | −790万 USD | −10.92億 USD | −942.1万 USD | −2287万 USD | 4830.7万 USD |
会社概要が更新されました 2026年10月11日.
発表済み実績と利用可能なコンセンサス予想。
発表済み実績と利用可能なコンセンサス予想。
第三者のアナリスト予想は変更される場合があり、GoAIの推奨ではありません。
| 種別 | 発効日 | 詳細 | 基準日 | 支払日 |
|---|---|---|---|---|
株式分割 | 2021年6月7日 | 2:1 | — | — |
株式分割 | 2018年1月2日 | 1,333:1,000 | — | — |
株式分割 | 2013年10月31日 | 3:2 | — | — |
株式分割 | 2009年12月16日 | 3:2 | — | — |
株式分割 | 2007年9月5日 | 3:2 | — | — |
株式分割 | 2004年1月2日 | 5:4 | — | — |
発効済み 2021年6月7日
2:1
発効済み 2018年1月2日
1,333:1,000
発効済み 2013年10月31日
3:2
発効済み 2009年12月16日
3:2
発効済み 2007年9月5日
3:2
発効済み 2004年1月2日
5:4
この株式へのエクスポージャーを報告している上場投資信託です。
Vanguard Morningstar Total Stock Market ETFVTI8044.06万0.00%2.3兆 USD0.03%$381.94+0.63%
iShares Russell 2000 ETFIWM6832.31万0.09%787.4億 USD0.19%$278.94+0.49%
Vanguard Morningstar Small-Cap ETFVB5785.11万0.03%1853億 USD0.03%$289.48+0.64%
U.S. Small Cap Value Portfolio ETF Class SharesDFSV4949.92万0.18%268.09億 USD0.33%$37.95-0.39%
Vanguard Morningstar Small-Cap Value ETFVBR3676.88万0.05%682億 USD0.05%$234.43+0.22%
Vanguard Extended Market ETFVXF2920.56万0.03%954億 USD0.05%$235+0.80%
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSM2354.05万0.15%158.4億 USD0.03%$53.45+0.17%
Invesco S&P SmallCap Momentum ETFXSMO2046.26万0.71%28.69億 USD0.35%$81.75+0.57%
Vanguard Morningstar Total Stock Market ETFVTI
iShares Russell 2000 ETFIWM
Vanguard Morningstar Small-Cap ETFVB
U.S. Small Cap Value Portfolio ETF Class SharesDFSV
Vanguard Morningstar Small-Cap Value ETFVBR
Vanguard Extended Market ETFVXF
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSM
Invesco S&P SmallCap Momentum ETFXSMOAIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。